AVA + Ad4-PA-1 + Ad4-PA-GPI-1
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anthrax Infection
Conditions
Anthrax Infection
Trial Timeline
Nov 1, 2013 → Sep 1, 2015
NCT ID
NCT01979406About AVA + Ad4-PA-1 + Ad4-PA-GPI-1
AVA + Ad4-PA-1 + Ad4-PA-GPI-1 is a phase 1 stage product being developed by Emergent BioSolutions for Anthrax Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT01979406. Target conditions include Anthrax Infection.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01979406 | Phase 1 | Completed |
Competing Products
15 competing products in Anthrax Infection